Rice lab’s injectable gel feeds steady dose of drugs to tumor cells An immunotherapy drug embedded in a slow-release hydrogel invented at Rice University in collaboration with the University... Read more
An antibody therapy against a key inflammatory molecule involved in migraines reduces the number of headaches that chronic migraine patients experience per month in a phase III trial A new s... Read more
Researchers from UT Southwestern Medical Center have developed a first-of-its-kind nanoparticle vaccine immunotherapy that targets several different cancer types. The nanovaccine consists of... Read more
Cabozantinib, a drug already used to treat patients with certain types of thyroid or kidney cancer, was able to eradicate invasive prostate cancers in mice by causing tumor cells to secrete... Read more
Immunotherapy has proven to be effective against many serious diseases. But to treat diseases in the brain, the antibodies must first get past the obstacle of the blood-brain barrier. In a n... Read more
University of Saskatchewan (U of S) scientists have developed a new immunotherapy technique that nearly eliminates the allergic response to peanut and egg white proteins in food-allergic mic... Read more
Macrophages are cells of the immune system that protect the host from invading pathogens. But in cancer, macrophages can be “hijacked” by tumors, and made to support their malignant growth a... Read more
A therapy that retrains the body’s immune system to fight cancer has provoked excitement after more than 90% of terminally ill patients reportedly went into remission. White blood cell... Read more
Immunotherapy is one of the hottest emerging areas of cancer research. After all, using the body’s own cells to fight cancer can be more effective and less invasive than flooding the e... Read more
Giving cancer patients aspirin at the same time as immunotherapy could dramatically boost the effectiveness of the treatment, according to new research published in the journal Cell today (T... Read more
An international study carried out with involvement of the MedUni Vienna is giving hope to patients with advanced prostate cancer. In just a few years’ time, Ipilumumab could be approved as... Read more
Immunotherapy is a treatment option that uses a person’s own immune system to fight cancer Moffitt Cancer Center has initiated a phase I clinical trial for a new immunotherapy drug, ID-G305,... Read more
Some of the newest therapies in the war on cancer remove the brakes cancer puts on the immune system, Georgia Health Sciences University researchers report. These immunotherapies, such as CT... Read more